Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)
EUR 62.2
(0.97%)
EUR 62.2
(0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 829.5 Million | 817.69 Million | 648.67 Million | 419.96 Million | 381.31 Million | 303.2 Million |
| Cost of Revenue | 346.16 Million | 320.95 Million | 285.21 Million | 198.24 Million | 184.82 Million | 210.83 Million |
| Gross Profit | 483.34 Million | 496.74 Million | 363.45 Million | 221.71 Million | 196.49 Million | 92.36 Million |
| Operating Expenses | 263.09 Million | 243 Million | 181.72 Million | 144.1 Million | 154.45 Million | 76.49 Million |
| Selling, General and Administrative Expenses | 147.02 Million | 213.83 Million | 148.57 Million | 113.9 Million | 120.3 Million | 41.77 Million |
| Research and Development Expenses | 25.36 Million | 23.86 Million | 27.44 Million | 23.8 Million | 29.3 Million | 32.37 Million |
| Other Expenses | 90.7 Million | -5.29 Million | -5.7 Million | -6.4 Million | -4.85 Million | -2.35 Million |
| Cost and Expenses | 609.25 Million | 563.96 Million | 466.94 Million | 342.35 Million | 339.28 Million | 287.33 Million |
| Operating Income | 220.25 Million | 253.73 Million | 181.73 Million | 77.61 Million | 42.03 Million | 15.87 Million |
| Interest Expense | 948 Thousand | 849 Thousand | 905 Thousand | 1.07 Million | 927 Thousand | - |
| Income Tax Expense | 50.1 Million | 58.3 Million | 29.55 Million | 11.52 Million | 2.6 Million | -1.21 Million |
| Earnings before Tax | 220.53 Million | 257.76 Million | 182.44 Million | 72.61 Million | 42.07 Million | 16.65 Million |
| Net Income | 170.33 Million | 199.66 Million | 153.07 Million | 61.05 Million | 39.27 Million | 17.89 Million |
| Earnings Per Share Basic | 3.20 | 3.73 | 2.76 | 1.10 | 0.71 | 0.35 |
| Earnings Per Share Diluted | 3.20 | 3.73 | 2.76 | 1.10 | 0.71 | 0.35 |
| Weighted Average Shares Outstanding | 53.19 Million | 53.46 Million | 55.4 Million | 55.38 Million | 55.18 Million | 51.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.19 Million | 53.46 Million | 55.4 Million | 55.38 Million | 55.18 Million | 51.22 Million |
| Gross Margin | 0.58 | 0.61 | 0.56 | 0.53 | 0.52 | 0.30 |
| EBIT Margin | 0.29 | 0.34 | 0.31 | 0.23 | 0.16 | 0.09 |
| Profit Margin | 0.21 | 0.24 | 0.24 | 0.15 | 0.10 | 0.06 |
| EBITDA | 238.01 Million | 276.6 Million | 204.71 Million | 93.27 Million | 60.24 Million | 27.91 Million |
| Earnings Before Tax Margin | 0.27 | 0.31 | 0.28 | 0.18 | 0.11 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 178.16 Million | 151.17 Million | 234.63 Million | 829.5 Million | 214.02 Million | 179.21 Million |
| Cost of Revenue | 67.84 Million | 65.5 Million | 103.07 Million | 365.42 Million | 85.13 Million | 93.82 Million |
| Gross Profit | 110.31 Million | 85.67 Million | 131.55 Million | 464.08 Million | 128.89 Million | 85.39 Million |
| Operating Expenses | 73.13 Million | 66.34 Million | 65.32 Million | 244.61 Million | 60.69 Million | 60.82 Million |
| Selling, General and Administrative Expenses | 32.56 Million | 32.3 Million | 56.92 Million | - | 54.99 Million | 55.21 Million |
| Research and Development Expenses | 6.29 Million | 6.1 Million | 8.4 Million | - | 5.7 Million | 5.61 Million |
| Other Expenses | 34.27 Million | - | - | -5.76 Million | - | - |
| Cost and Expenses | 140.97 Million | 131.85 Million | 168.4 Million | 610.03 Million | 145.82 Million | 154.64 Million |
| Operating Income | 37.18 Million | 19.11 Million | 66.23 Million | 219.47 Million | 68.2 Million | 24.57 Million |
| Interest Expense | - | - | 341 Thousand | 948 Thousand | 241 Thousand | 219 Thousand |
| Income Tax Expense | 7.75 Million | 4.04 Million | 14.75 Million | 50.1 Million | 16.16 Million | 5.47 Million |
| Earnings before Tax | 37.13 Million | 19 Million | 66.25 Million | 220.53 Million | 68.43 Million | 24.68 Million |
| Net Income | 29.38 Million | 14.96 Million | 51.5 Million | 170.33 Million | 52.18 Million | 19.18 Million |
| Earnings Per Share Basic | 0.55 | 0.29 | 0.99 | - | 0.98 | 0.36 |
| Earnings Per Share Diluted | 0.55 | 0.29 | 0.99 | - | 0.98 | 0.36 |
| Weighted Average Shares Outstanding | 53.37 Million | 51.82 Million | 51.82 Million | 51.82 Million | 53.36 Million | 53.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.37 Million | 51.82 Million | 51.82 Million | 51.82 Million | 53.36 Million | 53.36 Million |
| Gross Margin | 0.62 | 0.57 | 0.56 | 0.56 | 0.60 | 0.48 |
| EBIT Margin | 0.23 | 0.17 | 0.31 | - | 0.35 | 0.17 |
| Profit Margin | 0.16 | 0.10 | 0.22 | 0.21 | 0.24 | 0.11 |
| EBITDA | 40.59 Million | 25.73 Million | 72.74 Million | - | 74.15 Million | 30.61 Million |
| Earnings Before Tax Margin | 0.21 | 0.13 | 0.28 | 0.26 | 0.32 | 0.14 |
HBOR3
3166
KANDAGIRI
VIC
SLNHP
VICTMILL